AMRX — Amneal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $6.70bn
- $9.39bn
- $3.02bn
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta
U.S. STOCKS ON THE MOVE-Avery Dennison, Huntington Ingalls, XPO
Amneal gains after slightly lifting full-year forecast, Q2 beat
Amneal Q2 revenue beats on specialty segment growth
Lilly, Regeneron selected for US program to review new manufacturing plants faster (updated)
Focus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study
U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway
U.S. STOCKS ON THE MOVE-Certara, Otis, Twilio
U.S. STOCKS ON THE MOVE-Best Buy, Teleflex, Philip Morris
U.S. STOCKS ON THE MOVE-Adobe, GE Vernova, Calix
Brief: Kashiv Biosciences Agrees To Be Acquired By Amneal Pharmaceuticals To Create A Fully Integrated Global Biosimilar Leader
Amneal rises as Kashiv BioSciences buy lifts biosimilar push, outlook